Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entolimod Neo-adjuvant Study in Colorectal Cancer
NCT02715882Phase 2Unknown
- Sponsor
- BioLab Holdings
- Start
- Nov 2015
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of entolimod in colorectal cancer (CRC), sponsored by BioLab Holdings. Status: unknown.
02
Drugs
entolimod
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02715882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715882.